Expectant management is really “coming of age” in the USA

An excellent new review article in CA: A Cancer Journal of Clinicians, along with a research letter just published in the Journal of the American Medical Association (JAMA) have provided us with an important update on the value and the increasing acceptance of expectant management in the treatment of lower-risk forms of prostate cancer. … READ MORE …

Trends in the management of localized prostate cancer: 2000 to 2010

The international trend back toward increased use of more conservative management techniques (e.g., active surveillance and watchful waiting) for men with low-risk disease is again indicated in data from the Anglian region of the National Health Service in the UK. … READ MORE …

Slow but increasing uptake of observation in initial management of low-risk patients

A new article by Maurice et al. in the Canadian Urological Association Journal provides detailed information about the use of initial observation as a management strategy for low-risk prostate cancer between 2004 and 2011. … READ MORE …

Application of active surveillance in Australia after 2008

A newly published study in BJU International has reported on the application of active surveillance in Australia (and specifically in the state of Victoria) between 2008 and 2012. … READ MORE …

In 2004-07 most Medicare-eligible men were getting radiation therapy for first-line treatment of prostate cancer

In a second article in the new journal JAMA Oncology, researchers at the University of California Los Angeles suggest that 58 percent of all relatively recent treatment for prostate cancer was being given by radiation therapy of some type, and that indolent prostate cancer was being significantly over-treated. … READ MORE …

Is active surveillance appropriate for men with favorable intermediate-risk prostate cancer?

In a paper in the first issue of the new journal JAMA Oncology, a group of US-based researchers argue that data from a series of > 5,000 patients treated with first-line brachytherapy suggest that men with favorable intermediate-risk prostate cancer are actually good candidates for active surveillance. … READ MORE …

James Mohler talks prostate cancer on CureTalk

On Tuesday this week, Dr. James L. Mohler of Roswell Park Cancer Institute participated in an hour-long discussion on key issues related to the diagnosis and management of early stage prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,342 other followers